Trial Profile
A prospective, single-center, open-label, randomized study to evaluate suppression of the pituitary-ovarian axis with three different regimens of oral contraceptive pills
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/levonorgestrel (Primary) ; Ethinylestradiol
- Indications Pregnancy
- Focus Pharmacodynamics
- Sponsors Duramed Pharmaceuticals Inc
- 26 Oct 2007 Status change from in progress to completed
- 27 Aug 2007 The expected completion date for this trial is now 1 Jun 2006.
- 28 Oct 2006 New trial record.